We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$959M
AUM Growth
+$89.9M
Cap. Flow
+$164M
Cap. Flow %
17.13%
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Industrials 8.56%
3 Consumer Discretionary 7.01%
4 Materials 6.46%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
51
Praxis Precision Medicines
PRAX
$10.1B
$4.23M 0.44%
27,633
GTLS
52
DELISTED
Chart Industries
GTLS
$4.22M 0.44%
+24,585
New +$3.45M
DIS icon
53
Walt Disney
DIS
$181B
$4.12M 0.43%
30,000
-7,500
-20% -$1.08M
SOVO
54
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$3.94M 0.41%
277,834
-135,838
-33% -$1.82M
RXDX
55
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$3.78M 0.39%
100,000
+48,668
+95% +$1.92M
CRIS icon
56
Curis
CRIS
$7.83M
$3.77M 0.39%
3,963
+702
+22% +$896K
GTYH
57
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$3.75M 0.39%
1,159,600
MTEM
58
DELISTED
Molecular Templates, Inc.
MTEM
$3.52M 0.37%
68,088
WNS
59
DELISTED
WNS Holdings
WNS
$3.42M 0.36%
40,000
+12,500
+45% +$1.07M
SCYX icon
60
SCYNEXIS
SCYX
$52M
$3.12M 0.32%
99,631
BBBY
61
Bed Bath & Beyond
BBBY
$442M
$3.08M 0.32%
+77,000
New +$3.42M
MSAC
62
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$2.93M 0.31%
300,000
DOCU
63
PUT
DocuSign
DOCU
$11.5B
$2.68M 0.28%
+25,000
New +$2.87M
RDUS
64
CALL
DELISTED
Radius Health, Inc.
RDUS
$2.65M 0.28%
300,000
+143,200
+91% +$1.09M
BBBY
65
PUT
Bed Bath & Beyond
BBBY
$442M
$2.64M 0.28%
+66,000
New +$2.93M
GNCA
66
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.46M 0.26%
1,972,056
GEG icon
67
Great Elm Group
GEG
$69.3M
$2.28M 0.24%
1,259,049
DLTR icon
68
Dollar Tree
DLTR
$25.2B
$2.24M 0.23%
+14,000
New +$1.98M
NUVB icon
69
Nuvation Bio
NUVB
$2.32B
$2.23M 0.23%
423,500
TAP icon
70
Molson Coors Class B
TAP
$8.09B
$2.07M 0.22%
+38,750
New +$1.95M
HSY icon
71
Hershey
HSY
$36.6B
$2.04M 0.21%
+9,400
New +$1.91M
EUCR
72
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1.97M 0.21%
200,000
JSPR icon
73
Jasper Therapeutics
JSPR
$23.6M
$1.92M 0.2%
54,000
VINC
74
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.54M 0.16%
19,250
NVNO
75
enVVeno Medical
NVNO
$7.09M
$1.4M 0.15%
6,262

Similar funds

Kingdon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kingdon Capital Management deployed $164M of net new capital in Q1 2022, opening 30 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20.5M trimmed.

  • Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
  • Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
  • Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
  • Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
  • Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
  • Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
  • Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.

Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.